Erlotinib Completed Phase 1 Trials for Pancreatic Carcinoma Non-resectable / Pancreatic Cancer Metastatic Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00761345Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
NCT00954525Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer